These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23468026)

  • 1. Passive measles immunity in a Nigerian tertiary health care facility: the influence of human immunodeficiency virus infection on measles antibody levels in mother-infant pairs at birth.
    Baba UA; Mustapha MG; Ashir GM; Rabasa AI; Ibrahim BA; Ibrahim HA
    West Afr J Med; 2012; 31(4):243-6. PubMed ID: 23468026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal measles immunity in rural Kenya: the influence of HIV and placental malaria infections on placental transfer of antibodies and levels of antibody in maternal and cord serum samples.
    Scott S; Cumberland P; Shulman CE; Cousens S; Cohen BJ; Brown DW; Bulmer JN; Dorman EK; Kawuondo K; Marsh K; Cutts F
    J Infect Dis; 2005 Jun; 191(11):1854-60. PubMed ID: 15871118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of maternal haemoglobin as an indicator of maternal nutritional status on, maternal measles antibodies of mother-infant pairs at birth.
    Baba UA; Ashir GM; Mava Y; Gimba MS; Abubakar R; Ambe JP
    Afr Health Sci; 2013 Dec; 13(4):940-6. PubMed ID: 24940316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired neutralizing activity by transplacental measles antibodies in infants born to HIV-1-infected mothers.
    Farouk S; Navér L; Smedman L
    Acta Paediatr; 2012 Nov; 101(11):e500-4. PubMed ID: 22816388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal HIV infection associated with reduced transplacental transfer of measles antibodies and increased susceptibility to disease.
    Jallow S; Cutland CL; Masbou AK; Adrian P; Madhi SA
    J Clin Virol; 2017 Sep; 94():50-56. PubMed ID: 28759772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral studies of mothers with human immunodeficiency virus infection at delivery and their infants in the first 3 days of life.
    Sison AV; Brandt CD; Rakusan TA; Wientzen R; Fuccillo DA; Sever JL
    Pediatr AIDS HIV Infect; 1996 Oct; 7(5):325-30. PubMed ID: 11361490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants.
    Scott S; Moss WJ; Cousens S; Beeler JA; Audet SA; Mugala N; Quinn TC; Griffin DE; Cutts FT
    Clin Infect Dis; 2007 Dec; 45(11):1417-24. PubMed ID: 17990222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review.
    Cáceres VM; Strebel PM; Sutter RW
    Clin Infect Dis; 2000 Jul; 31(1):110-9. PubMed ID: 10913406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced Transplacental Transfer of Group B Streptococcus Surface Protein Antibodies in HIV-infected Mother-Newborn Dyads.
    Dzanibe S; Adrian PV; Mlacha SZK; Dangor Z; Kwatra G; Madhi SA
    J Infect Dis; 2017 Feb; 215(3):415-419. PubMed ID: 27932617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placental Transfer of Respiratory Syncytial Virus Antibody Among HIV-Exposed, Uninfected Infants.
    Patel SM; Jallow S; Boiditswe S; Madhi SA; Feemster KA; Steenhoff AP; Arscott-Mills T; Muthoga C; Ajibola G; Shapiro R; Shah SS; Cunningham CK; Kelly MS
    J Pediatric Infect Dis Soc; 2020 Jul; 9(3):349-356. PubMed ID: 31549157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection.
    Supapol WB; Remis RS; Raboud J; Millson M; Tappero J; Kaul R; Kulkarni P; McConnell MS; Mock PA; Culnane M; McNicholl J; Roongpisuthipong A; Chotpitayasunondh T; Shaffer N; Butera S
    J Infect Dis; 2008 May; 197(10):1369-77. PubMed ID: 18419578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi.
    Helfand RF; Witte D; Fowlkes A; Garcia P; Yang C; Fudzulani R; Walls L; Bae S; Strebel P; Broadhead R; Bellini WJ; Cutts F
    J Infect Dis; 2008 Nov; 198(10):1457-65. PubMed ID: 18828743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
    Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
    J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dynamic maternal measles antibody level in infants: a longitudinal study].
    Lu L; Cao YM; Yang QY; He Q; Dong ZQ; Di B; Fu CX; Wang M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 May; 37(5):663-7. PubMed ID: 27188358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High maternal HIV-1 viral load during pregnancy is associated with reduced placental transfer of measles IgG antibody.
    Farquhar C; Nduati R; Haigwood N; Sutton W; Mbori-Ngacha D; Richardson B; John-Stewart G
    J Acquir Immune Defic Syndr; 2005 Dec; 40(4):494-7. PubMed ID: 16280707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of placental malaria infection and maternal hypergammaglobulinaemia on materno-foetal transfer of measles and tetanus antibodies in a rural west African population.
    Okoko BJ; Wesuperuma LH; Ota MO; Banya WA; Pinder M; Gomez FS; Osinusi K; Hart AC
    J Health Popul Nutr; 2001 Jun; 19(2):59-65. PubMed ID: 11503348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of in-utero HIV exposure and antiretroviral treatment strategies on measles susceptibility and immunogenicity of measles vaccine.
    Simani OE; Adrian PV; Violari A; Kuwanda L; Otwombe K; Nunes MC; Cotton MF; Madhi SA
    AIDS; 2013 Jun; 27(10):1583-91. PubMed ID: 24047763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early waning of maternal measles antibodies in era of measles elimination: longitudinal study.
    Leuridan E; Hens N; Hutse V; Ieven M; Aerts M; Van Damme P
    BMJ; 2010 May; 340():c1626. PubMed ID: 20483946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Sperling RS; Shapiro DE; Coombs RW; Todd JA; Herman SA; McSherry GD; O'Sullivan MJ; Van Dyke RB; Jimenez E; Rouzioux C; Flynn PM; Sullivan JL
    N Engl J Med; 1996 Nov; 335(22):1621-9. PubMed ID: 8965861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive immunity to measles in the breastmilk and cord blood of some nigerian subjects.
    Oyedele OO; Odemuyiwa SO; Ammerlaan W; Muller CP; Adu FD
    J Trop Pediatr; 2005 Feb; 51(1):45-8. PubMed ID: 15601649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.